吸入麻酔の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

吸入麻酔市場の世界需要は、2023年の20億8,000万米ドルから2032年にはほぼ47億3,000万米ドルの市場規模に達すると推定され、調査期間2024-2032年のCAGRは9.56%です。

吸入麻酔薬は、手術室での全身麻酔の導入と維持に使用されます。最も一般的な吸入麻酔薬は、デスフルラン、イソフルラン、亜酸化窒素、セボフルラン、キセノンです。吸入麻酔薬は肺から体内に入り、血液によって組織に運ばれることで作用します。吸入麻酔薬の用途としては、鎮静、難治性気管支痙攣、抗痙攣薬に反応しないてんかん状態のコントロールなどが知られています。

市場力学

がん、心臓血管、脊椎、整形外科、呼吸器、消化器、神経、その他に関連する疾患など、さまざまな疾病に罹患する高齢化人口の増加が成長を刺激すると予想されます。侵襲的処置の増加も需要増に寄与しています。緊急症例の増加や、注射麻酔薬に対する吸入麻酔薬の利点も、市場の成長を加速させています。しかし、心不整脈、神経毒性、術後の悪心・嘔吐、呼吸抑制、刺激性など、吸入麻酔薬に関連する副作用が予測期間中の成長を阻害すると予測されています。

この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは吸入麻酔の世界市場における各セグメントの包括的な評価も与えます。吸入麻酔産業の成長と動向は、この研究に全体的なアプローチを提供します。

市場セグメンテーション

吸入麻酔市場レポートでは、国別および地域別のセグメントに関する詳細なデータを提供することで、戦略担当者が各製品やサービスのターゲット層を特定し、今後のビジネスチャンスに役立てることができます。

薬剤別

• セボフルラン
• デスフルラン
• イソフルラン
• その他

用途別

• 導入
• メンテナンス

用途別

• 病院
• 外来手術センター
• その他

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおける吸入麻酔市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、本レポートは、すべての著名な地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 吸入麻酔-産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 業界動向
• ポーターのファイブフォース分析
• 市場の魅力分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 吸入麻酔の世界市場分析：薬剤別

• 薬剤別概要
• 実績データと予測データ
• 薬剤別分析
• セボフルラン
• デスフルラン
• イソフルラン
• その他

第6章 吸入麻酔の世界市場分析：用途別

• 概要：用途別
• 実績データと予測データ
• 分析：用途別
• 導入麻酔
• メンテナンス

第7章 世界の吸入麻酔市場分析：最終用途別

• 概要：最終用途別
• 実績データと予測データ
• 最終用途別分析
• 病院
• 外来手術センター
• その他

第8章 吸入麻酔の世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州セグメント別
  • 欧州国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋セグメント別
  • アジア太平洋国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他アジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカセグメント別
  • ラテンアメリカ国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他ラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカセグメント別
  • 中東・アフリカ国別一覧
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ

第9章 吸入麻酔企業の競合情勢

• 吸入麻酔市場の競合
• 提携/協力/合意
• 合併・買収
• 新製品の発売
• その他の開発

第10章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• Halocarbon Products Corporation
• Baxter
• AbbVie
• Lunan Pharmaceutical Group

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Drug (USD MN)
• Sevoflurane Market Sales By Geography (USD MN)
• Desflurane Market Sales By Geography (USD MN)
• Isoflurane Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Induction Market Sales By Geography (USD MN)
• Maintenance Market Sales By Geography (USD MN)
• Analysis By End-use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Inhalation Anesthesia Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Inhalation Anesthesia Report
• Market Research Process
• Market Research Methodology
• Global Inhalation Anesthesia Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Drug
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-use
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Drug (USD MN)
• Sevoflurane Market Sales By Geography (USD MN)
• Desflurane Market Sales By Geography (USD MN)
• Isoflurane Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Induction Market Sales By Geography (USD MN)
• Maintenance Market Sales By Geography (USD MN)
• Global Market Analysis By End-use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Inhalation Anesthesia Market is presumed to reach the market size of nearly USD 4.73 Billion by 2032 from USD 2.08 Billion in 2023 with a CAGR of 9.56% under the study period 2024-2032.

Inhalation anesthetics are used for induction and maintenance of general anesthesia in the operating room. The most common inhalational anesthetics are desflurane, isoflurane, nitrous oxide, sevoflurane, and xenon. Inhalation anesthetics work by entering the body through the lungs and are carried by the blood to tissues. The known inhaled anesthetic applications are sedation, refractory bronchospasm, and control of status epilepticus unresponsive to anticonvulsant medications.

MARKET DYNAMICS

Expanding aging population suffering from various diseases, including cancer, disorders related to cardiovascular, spinal, orthopedic, respiratory, gastrointestinal, neurological, and others are anticipated to stimulate the growth. The increasing number of invasive procedures is also contributing to the demand increase. The rise in the number of emergency cases and the benefit of inhalation anesthetics over injectable anesthetics is also accelerating the market's growth. However, Side effects associated with Inhalation anesthetics such as cardiac arrhythmias, neurotoxicity, postoperative nausea and vomiting, respiratory depression, and irritation are foreseen to impede growth during the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Inhalation Anesthesia. The growth and trends of Inhalation Anesthesia industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Inhalation Anesthesia market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug

• Sevoflurane
• Desflurane
• Isoflurane
• Others

By Application

• Induction
• Maintenance

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Inhalation Anesthesia market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Inhalation Anesthesia market include Halocarbon Products Corporation, Baxter, AbbVie, Lunan Pharmaceutical Group, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. INHALATION ANESTHESIA - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Drug
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL INHALATION ANESTHESIA MARKET ANALYSIS BY DRUG

• 5.1. Overview By Drug
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Drug
• 5.4. Sevoflurane Historic and Forecast Sales By Regions
• 5.5. Desflurane Historic and Forecast Sales By Regions
• 5.6. Isoflurane Historic and Forecast Sales By Regions
• 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL INHALATION ANESTHESIA MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Application
• 6.4. Induction Historic and Forecast Sales By Regions
• 6.5. Maintenance Historic and Forecast Sales By Regions

7. GLOBAL INHALATION ANESTHESIA MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-use
• 7.2. Historical and Forecast Data
• 7.3. Analysis By End-use
• 7.4. Hospitals Historic and Forecast Sales By Regions
• 7.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL INHALATION ANESTHESIA MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE INHALATION ANESTHESIA COMPANIES

• 9.1. Inhalation Anesthesia Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF INHALATION ANESTHESIA INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Halocarbon Products Corporation
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Baxter
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. AbbVie
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Lunan Pharmaceutical Group
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies